[1]
|
管惠静, 杜丹, 孙明祎, 等. 四君子汤加减治疗慢性心力衰竭气虚痰瘀证的临床效果[J]. 世界中医药, 2019, 14(7): 1817-1820.
|
[2]
|
石娓霞. 温阳活血益心方联合西药治疗慢性心力衰竭的临床观察[J]. 中国民间疗法, 2021, 29(10): 89-92.
|
[3]
|
国家心血管病医疗质量控制中心专家委员会心力衰竭专家工作组. 2020中国心力衰竭医疗质量控制报告[J]. 中国循环杂志, 2021, 36(3): 221-238.
|
[4]
|
Roger, V.L. (2021) Epidemiology of Heart Failure: A Contemporary Perspective. Circulation Research, 128, 1421-1434. https://doi.org/10.1161/CIRCRESAHA.121.318172
|
[5]
|
Zhang, Y.H., Zhang, J., Butler, J., et al. (2017) Contem-porary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results from the China Heart Failure (China-HF) Registry. Journal of Cardiac Failure, 23, 868-875. https://doi.org/10.1016/j.cardfail.2017.09.014
|
[6]
|
Mcdonagh, T.A., Metra, M., Adamo, M., et al. (2021) 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal, 42, 3599-3726.
|
[7]
|
李爱玲, 王万庆, 许永梅. 慢性充血性心力衰竭患者血清CA125、cTnT和BNP水平变化及临床诊断意义[J]. 国际医药卫生导报, 2018, 24(23): 3569-3572.
|
[8]
|
Belknap, R.W. (2019) Current Medical Man-agement of Pulmonary Tuberculosis. Thoracic Surgery Clinics, 29, 27-35.
https://doi.org/10.1016/j.thorsurg.2018.09.004
|
[9]
|
Perez, B.H. and Gipson, I.K. (2008) Focus on Molecules: Human Mucin MUC16. Thoracic Surgery Clinics, 87, 400-401. https://doi.org/10.1016/j.exer.2007.12.008
|
[10]
|
Bast Jr., R.C., Feeney, M., Lazarus, H., et al. (1981) Reactivity of a Monoclonal Antibody with Human Ovarian Carcinoma. Journal of Clinical Investigation, 68, 1331-1337. https://doi.org/10.1172/JCI110380
|
[11]
|
Sikaris, K.A. (2011) CA125—A Test with a Change of Heart. Heart, Lung and Circulation, 20, 634-640.
https://doi.org/10.1016/j.hlc.2010.08.001
|
[12]
|
Turgut, O., tandogan, L., Yilmaz, M.B., et al. (2011) CA125 in Heart Failure: Implications for Immunoinflammatoty Activity. International Journal of Cardiology, 146, 99-100. https://doi.org/10.1016/j.ijcard.2010.05.077
|
[13]
|
Huang, F., Chen, J., Liu, Y., et al. (2012) New Mechanism of Elevated CA125 in Heart Failure: The Mechanical Stress and Inflammatory Stimuli Initiate CA125 Synthesis. Medical Hypotheses, 79, 381-383.
https://doi.org/10.1016/j.mehy.2012.05.042
|
[14]
|
赵龙, 张惠卿, 王前, 等. STMN1及UBE2C在胃癌组织中的表达及其临床意义[J]. 现代肿瘤医学, 2021, 29(7): 1187-1191
|
[15]
|
贺玲玲. 肝细胞癌中UBE2C及STMN1的表达及意义[D]: [硕士学位论文]. 承德: 承德医学院, 2021.
|
[16]
|
Frump, A.L., Bonnet, S., De Jesus, P.V., et al. (2018) The Emerging Role of Angiogenesis in Adaptive and Maladaptive Right Ventricular Remodeling in Pulmonary Hyper-tension. American Journal of Physiology-Lung Cellular and Molecular Physiology, 314, L443-L460. https://doi.org/10.1152/ajplung.00374.2017
|
[17]
|
Nagele, H., Bahlo, M., Klapdor, R., et al. (1999) CA125 and Its Relation to Cardiac Function. American Heart Journal, 137, 1044-1049. https://doi.org/10.1016/S0002-8703(99)70360-1
|
[18]
|
Faggiano, P., D’Aloia, A., Brentana, L., et al. (2005) Serum Levels of Different Tumour Markers in Patients with Chronic Heart Failure. European Journal of Heart Failure, 7, 57-61. https://doi.org/10.1016/j.ejheart.2004.04.009
|
[19]
|
Kosar, F., Aksoy, Y., Ozguntekin, G., et al. (2006) Rela-tionship between Cytokines and Tumour Markers in Patients with Chronic Heart Failure. European Journal of Heart Failure, 8, 270-274.
https://doi.org/10.1016/j.ejheart.2005.09.002
|
[20]
|
Kokilambigai, K.S., Lakshmi, K.S., Sai Susmitha, A., et al. (2020) Linezolid—A Review of Analytical Methods in Pharmaceuticals and Biological Matrices. Critical Reviews in Analytical Chemistry, 50, 179-188.
https://doi.org/10.1080/10408347.2019.1599709
|
[21]
|
Huang, F., Chen, J., Liu, Y., et al. (2012) New Mechanism of Elevated CA125 in Heart Failure: The Mechanical Stress and Inflammatory Stimuli Initiate CA125 Synthesis. Medical Hypotheses, 79, 381-383.
https://doi.org/10.1016/j.mehy.2012.05.042
|
[22]
|
Faggiano, P., D’aloia, A., Brentana, L., et al. (2014) Serum Levels of Different Tumour Markers in Patients with Chronic Heart Failure. European Journal of Heart Failure, 7, 57-61. https://doi.org/10.1016/j.ejheart.2004.04.009
|
[23]
|
陈琳. 急性心肌梗死(AMI)患者CA125 水平与心功能状态之间的关系分析[J]. 智慧健康, 2020, 6(2): 14-15.
|
[24]
|
邢国庆. 血清HSP27 CA125UA水平变化与老年慢性心力衰竭患者心功能的关联性[J]. 内蒙古医学杂志, 2020, 52(3): 318-319.
|
[25]
|
Espriella, R., Miana, G., Santas, E., et al. (2021) Effects of Empagliflozin on CA125 Trajectory in Patients with Chronic Congestive Heart Failure. International Journal of Cardiology, 7, 521-522.
https://doi.org/10.1016/j.ijcard.2021.06.045
|
[26]
|
马锦玲, 刘宏伟, 程友琴. 影响老年充血性心力衰竭患者血清CA125的相关因素分析[J]. 中国综合临床, 2011, 27(3): 252-255.
|
[27]
|
Ming, Z., Shenwen, F.U., Aixia, L., et al. (2016) The Relationship between CA125 Levelsand Inflammatory Cytokines in Patients with Chronic Heart Failure. Journal of Electrocardiology, 2, 889-892.
|
[28]
|
Stanciu, A.E., Stanciu, M.M. and Vatasescu, R.G. (2018) NT-proBNP and CA125 Levels Are Associated with Increased Pro-Inflammatory Cytokines in Coronary Sinus Serum of Patients with Chronic Heart Failure. Cytokines, 111, 13-19. https://doi.org/10.1016/j.cyto.2018.07.037
|
[29]
|
张贤, 齐祥, 董忻悦, 等. 小肠细菌过度生长与慢性心力衰竭患者心功能的关系[J]. 江苏大学学报(医学版), 2021, 31(3): 251-256, 276.
|
[30]
|
Rong, X., Yunke, Z., Guoping, L. and Zhenyue, C. (2015) Clinical and Prognostic Value of Ele-vated CA125 Levels in Patients with Coronary Heart Disease. Herz, 40, 690-694. https://doi.org/10.1007/s00059-014-4109-y
|
[31]
|
Yilmaz, H., Gürel, O.M., Celik, H.T., et al. (2014) CA 125 Levels and Left Ventricular Function in Patients with End-Stage Renal Disease on Maintenance Hemodialysis. Renal Failure, 36, 210-216.
https://doi.org/10.3109/0886022X.2013.859528
|
[32]
|
Hung, C.L., Hung, T.C., Liu, C.C., et al. (2012) Relation of Carbohydrate Antigen-125 to Left Atrial Remodeling and Its Prognostic Usefulness in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction in Women. The American Journal of Cardiology, 110, 993-1000. https://doi.org/10.1016/j.amjcard.2012.05.030
|
[33]
|
Mansour, I.N., Napan, S., Tarek Alahdab, M., et al. (2010) Carbohydrate Antigen 125 Predicts Long-Term Mortality in African American Patients with Acute Decompensated Heart Failure. Congestive Heart Failure, 16, 15-20.
https://doi.org/10.1111/j.1751-7133.2009.00110.x
|
[34]
|
Ordu, S., Ozhan, H., Alemdar, R., et al. (2012) Carbohy-drate Antigen-125 and N—Terminal Pro-Brain Natriuretic Peptide Levels: Compared in Heart Failure Prognostication. Texas Heart Institute Journal, 39, 30-35.
|
[35]
|
Antonini-Canterin, F., Popescu, B.A., Popescu, A.C., et al. (2008) Heart Failure in Patients with Aortic Stenosis: Clinical and Prognostic Significance of Carbohydrate Antigen 125 and Brain Natriuretic Peptide Measurement. International Journal of Cardiology, 128, 406-412. https://doi.org/10.1016/j.ijcard.2007.05.039
|
[36]
|
Bulska-Bdkowska, W., Chemecka, E., Owczarek, A.J., et al. (2019) CA125 as a Marker of Heart Failure in the Older Women: Population-Based Analysis. Journal of Clinical Medi-cine, 8, Article 607. https://doi.org/10.3390/jcm8050607
|
[37]
|
张胜豪, 刘恒亮, 毛磊, 等. 血清糖类抗原125及脑钠肽水平对心肌梗死后心力衰竭发生及严重程度的预测价值[J]. 中国动脉硬化杂志, 2019, 27(1): 55-60.
|